At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD, from the German Breast Group, Neu-Isenburg, Germany, discusses changes in tumour expression of HER2 and hormone receptor status and pathological complete response (pCR) after neoadjuvant chemotherapy in a Japanese breast cancer registry.
Login to continue
Members
Create Account
Create your own personal healthcare feed, full of the latest content from across our divisions.
Register
![EMJ Oncology 10 [Supplement 6] 2022 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2022/03/EMJ-Oncology-10-Supplement-6-2022-Feature-Image-940x563.jpg)
![EMJ Oncology 10 [Supplement 5] 2022 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2022/03/EMJ-Oncology-10-Supplement-5-2022-Feature-Image-1-940x563.jpg)